| English
AFRICA
2 min read
Ebola death toll reaches 600 in DR Congo as UN urges end to fighting
The outbreak is being driven by the rare Bundibugyo species of Ebola, for which there are no approved vaccines or treatments.
Ebola death toll reaches 600 in DR Congo as UN urges end to fighting
A Congolese nun carries a child cleared of Ebola at a treatment centre in Bunia, eastern DRC, June 2026.

The Ebola outbreak in the Democratic Republic of Congo has now claimed 600 lives, figures published by the World Health Organization showed Thursday - only three days after the figure topped 500.

Updated numbers issued by the UN health agency showed there have been 1,759 confirmed cases in DR Congo since the outbreak was declared in mid-May, including 600 confirmed deaths.

Two other people have died in neighbouring Uganda, where 17 patients have recovered out of 20 total confirmed cases.

The UN has also called for an immediate end to fighting between the armed forces and the M23 rebels in eastern Congo, the epicentre of the current Ebola outbreak.

UN human rights chief Volker Turk said he deplored the violent impact on civilians, and called for international efforts to help de-escalate tensions.

‘Deeply troubling’

"It is deeply troubling that despite the agreements reached as part of the ongoing peace processes, fighting continues unabated in eastern DRC - killing, injuring and displacing civilians and destroying livelihoods," he said in a statement.

The WHO's figures for the DRC, which come from the health authorities in the vast country, show that the outbreak there has a case fatality rate of 34 percent.

"The outbreak continues to expand, and its true scale has not yet been fully established," Anne Ancia, the WHO's representative in the DRC, said Tuesday.

A total of 285 patients in the DRC have recovered, while 304 suspected cases of the viral haemorrhagic fever are under investigation.

No approved vaccines

The outbreak in northeastern DRC has hit four provinces but is focused on Ituri province.

The outbreak is being driven by the rare Bundibugyo species of Ebola, for which there are no approved vaccines or treatments.

The trial of two potential treatments for Bundibugyo began in the DRC on July 2.

The trial is evaluating the effectiveness of the monoclonal antibody MBP134 and the antiviral drug remdesivir, alone and in combination.

Ebola spreads through close contact and infected bodily fluids.

SOURCE:TRT Afrika and agencies